Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): role of PKC, MAPKs, and NF-κB
Authors:
- Parvaneh RafieePRParvaneh Rafiee
- Victoria M. NelsonVNVictoria M. Nelson
- Sharon ManleySMSharon Manley
- Michael WellnerMWMichael Wellner
- Martin FloerMFMartin Floer
- David G. BinionDBDavid G. Binion
- Reza ShakerRSReza Shaker
- 1 February 2009
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 296 (2) , G388-G398
Abstract
Human esophageal epithelial cells play a key role in esophageal inflammation in response to acidic pH during gastroesophageal reflux disease (GERD), increasing secretion of IL-6 and IL-8. The mechanisms underlying IL-6 and IL-8 expression and secretion in esophageal epithelial cells after acid stimulation are not well characterized. We investigated the role of PKC, MAPK, and NF-κB signaling pathways and transcriptional regulation of IL-6 and IL-8 expression in HET-1A cells exposed to acid. Exposure of HET-1A cells to pH 4.5 induced NF-κB activity and enhanced IL-6 and IL-8 secretion and mRNA and protein expression. Acid stimulation of HET-1A cells also resulted in activation of MAPKs and PKC (α and ε). Curcumin, as well as inhibitors of NF-κB (SN-50), PKC (chelerythrine), and p44/42 MAPK (PD-098059) abolished the acid-induced expression of IL-6 and IL-8. The JNK inhibitor SP-600125 blocked expression/secretion of IL-6 but only partially attenuated IL-8 expression. The p38 MAPK inhibitor SB-203580 did not inhibit IL-6 expression but exerted a stronger inhibitory effect on IL-8 expression. Together, these data demonstrate that 1) acid is a potent inducer of IL-6 and IL-8 production in HET-1A cells; 2) MAPK and PKC signaling play a key regulatory role in acid-mediated IL-6 and IL-8 expression via NF-κB activation; and 3) the anti-inflammatory plant compound curcumin inhibits esophageal activation in response to acid. Thus IL-6 and IL-8 expression by acid may contribute to the pathobiology of mucosal injury in GERD, and inhibition of the NF-κB/proinflammatory cytokine pathways may emerge as important therapeutic targets for treatment of esophageal inflammation.Keywords
This publication has 29 references indexed in Scilit:
- Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled TrialClinical Gastroenterology and Hepatology, 2006
- Platelet-activating factor and prostaglandin E2impair esophageal ACh release in experimental esophagitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Inflammation induced changes in arachidonic acid metabolism in cat LES circular muscleAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Mechanisms for Lysophosphatidic Acid-induced Cytokine Production in Ovarian Cancer CellsJournal of Biological Chemistry, 2004
- Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in VivoJournal of Biological Chemistry, 2003
- Increased release of interleukin-6 by oesophageal mucosa in children with reflux oesophagitisEuropean Journal of Gastroenterology & Hepatology, 1999
- Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett’s esophagusAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1998
- Involvement of NF‐κB in the regulation of cyclooxygenase‐2 protein expression in LPS‐stimulated J774 macrophagesFEBS Letters, 1997
- Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.Journal of Clinical Investigation, 1996
- Patterns of Gastroesophageal Reflux in Health and DiseaseAnnals of Surgery, 1976